Single domain antibody – Potential applications

Orally available single domain antibodies against ''E. coli''-induced diarrhoea in piglets have been developed and successfully tested. Other diseases of the gastrointestinal tract, such as inflammatory bowel disease and colon cancer, are also possible targets for orally available sdAbs.

Orally available single domain antibodies against ''E. coli''-induced diarrhoea in piglets have been developed and successfully tested. Other diseases of the gastrointestinal tract, such as inflammatory bowel disease and colon cancer, are also possible targets for orally available sdAbs.

Detergent stable species targeting a surface protein of ''Malassezia furfur'' have been engineered for the use in anti-dandruff shampoos.

ALX-0081, a single domain antibody targeting von Willebrand factor is in clinical trials for the prevention of thrombosis in patients with acute coronary syndrome. A Phase II study examining ALX-0081 in high risk percutaneous coronary intervention has started in September 2009.

Ablynx expects that their Nanobodies might cross the blood-brain barrier and permeate into large solid tumours easier than whole antibodies, which would allow for the development of drugs against brain cancers.


Adapted from the Wikipedia article Single domain antibody, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki








Related Articles

RheumatoidDisease diagnosis and therapy Detection of particular antibodies is a very common form of medical diagnostics, and applications such as serology depen...
ProteinAs a protein and antibody solutions provider, GenWay has a multi-functional technology platform specialized in using genes, proteins, antibodies, and ...
Monoclonal antibody technologyBharatbook.com added a new report which gives information on Conference on Re-emerging infectious diseases...
Monoclonal antibody productionTwo Percent of All Female Newborns in the United States Are at Risk of Getting Ovarian Cancer As many as 30,000 U.S. women will be diagnosed with ov...
Monoclonal antibody technologyDr. Lorne Tyrrell pioneered lamivudine as the standard treatment for hepatitis B virus (HBV). Now a success, he observed the drug's shortcomings. Now ...